Literature DB >> 18221084

Therapeutic targeting of endothelial dysfunction in chronic diabetic complications.

Zia A Khan1, Subrata Chakrabarti.   

Abstract

In an ever-increasing population of patients with diabetes, morbidity and mortality due to the secondary complications require prompt identification of the underlying mechanisms. Aberration in the vascular endothelial cell function may be a key element in the development and progression of the chronic diabetic complications. We present the hypothesis that preservation and restoration of the endothelial cell function may potentially be the most efficient means of targeting the adverse effects of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18221084     DOI: 10.2174/157489006777442531

Source DB:  PubMed          Journal:  Recent Pat Cardiovasc Drug Discov


  5 in total

1.  Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.

Authors:  Meghan A Piccinin; Zia A Khan
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

Review 2.  Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise.

Authors:  Emily C Keats; Zia A Khan
Journal:  Cardiovasc Diabetol       Date:  2012-04-23       Impact factor: 9.951

3.  Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose.

Authors:  Emily Keats; Zia A Khan
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

4.  Curcumin Analogs Reduce Stress and Inflammation Indices in Experimental Models of Diabetes.

Authors:  Saumik Biswas; Shali Chen; Guang Liang; Biao Feng; Lu Cai; Zia A Khan; Subrata Chakrabarti
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-18       Impact factor: 5.555

5.  Synthesis and biological evaluation of stilbene derivatives coupled to NO donors as potential antidiabetic agents.

Authors:  Bing Wang; Teng Liu; Zhongyu Wu; Lei Zhang; Jie Sun; Xiaojing Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.